Fundraising FoxCycuria
Graz, AT · 1 known investors
Find your way into Cycuria
Sign up to see every warm intro you have to Cycuria
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cycuria team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cycuria Therapeutics develops engineered biologics to treat blood cancers, targeting leukemic cells and their progenitor stem cells while sparing healthy blood formation, with an initial focus on Acute Myeloid Leukemia (AML). Its lead program is CUR-101, aimed at patients including older or unfit individuals who cannot tolerate intensive chemotherapy or stem cell transplants.
Founders & leadership
DN
Dr. Nisit KhandelwalCo-Founder & CEO
PD
Prof. Dr. Philipp J. JostInventor & Co-Founder
Investors · 1
Frequently asked questions
- What does Cycuria do?
- Cycuria Therapeutics develops engineered biologics to treat blood cancers, targeting leukemic cells and their progenitor stem cells while sparing healthy blood formation, with an initial focus on Acute Myeloid Leukemia (AML). Its lead program is CUR-101, aimed at patients including older or unfit individuals who cannot tolerate intensive chemotherapy or stem cell transplants.
- Who founded Cycuria?
- Cycuria was founded by Dr. Nisit Khandelwal, Prof. Dr. Philipp J. Jost.
- Who are Cycuria's investors?
- Cycuria's investors include Wieland Capital.
- Where is Cycuria headquartered?
- Cycuria is headquartered in Graz, AT.